In this episode, Karen Kobelski, VP and General Manager of Clinical Surveillance of Wolters Kluwer Health, discusses their new offerings that are helping clinicians respond to the Covid-19 pandemic. She also discusses how health systems are adopting the new interoperability rule and how it will result in better healthcare outcomes.
At Wolters Kluwer Health, the mission is to bring the latest evidence-based medicine to the benefit of clinicians, learning communities, and patients. Their infection surveillance system and pharmacy surveillance system are helping hospitals and health systems respond and cope with the current Covid-19 crisis. Karen believes that with the new interoperability rule in place, patients can be treated in a lot of different ways if they have access to their health records. She further states that telehealth will stay with us for a long time, and traditional visits to hospitals will be replaced by virtual treatments, just like everyone is working virtually today.